Google Apple: Which Biggest AI Stock Is Best Right Now
Google and Apple are leading the AI stock surge. This piece weighs valuation, growth, and cash flow to answer which m...
Who Should Avoid Automated Investing
Investors needing highly customized portfolios or personal financial planning may prefer traditional advisory services over automated solutions.
24,498 articles
Lawmakers Fight to Solve $24,480 Social Security Limit
Lawmakers are rushing to end the $24,480 earnings limit that reduces Social Security benefits for retirees who keep w...
Warren Buffett Behind Berkshire: Alphabet Bet Explained
Warren Buffett behind Berkshire surprised many by boosting a tech giant stake. This article breaks down why Alphabet ...
Crypto Starts 2026 Strong: Venezuela's Market Impact
As 2026 kicks off, crypto markets show surprising resilience. Venezuela's evolving policy and remittance dynamics are...
Prediction: After Beating Last 15 Years, Vanguard Tops 2026
For more than a decade, one Vanguard ETF quietly outpaced the broad market. This article dives into why its growth ti...
Trump Backs Stock-Trade Congress Ban After State of the Union
In his State of the Union address, Trump urged lawmakers to ban stock trading by Congress. The move launches a high-s...
Berkshire Hathaway Shareholders Just Heard a New CEO Letter
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
Vinod Khosla Thinks the Future of Tax Policy for Low Earners
A leading Silicon Valley investor has floated a dramatic plan to end income taxes for people earning under $100,000 b...
This Biotech’s Stock Soaring After FDA Official Exits
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
SCHD Investors: Mark Your Calendar for March Rebalance
SCHD will conduct its annual reconstitution on March 23, trimming energy exposure and leaning more on financials to d...
Zoom (ZM) Stock Price Outlook: 2026 to 2030 for Investors
Zoom's post-pandemic growth trajectory remains uncertain as investors weigh AI opportunities and competition. This pi...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status